Previous 10 | Next 10 |
The following slide deck was published by Lantheus Holdings, Inc. in conjunction with their 2021 Q1 earnings call. For further details see: Lantheus Holdings, Inc. 2021 Q1 - Results - Earnings Call Presentation
Image source: The Motley Fool. Lantheus Holdings Inc (NASDAQ: LNTH) Q1 2021 Earnings Call May 4, 2021 , 8:00 a.m. ET Operator Continue reading For further details see: Lantheus Holdings Inc (LNTH) Q1 2021 Earnings Call Transcript
Lantheus (NASDAQ:LNTH) is scheduled to announce Q1 earnings results on Tuesday, May 4th, before market open.The consensus EPS Estimate is -$0.01 and the consensus Revenue Estimate is $87.24M (-3.8% Y/Y).Over the last 2 years, LNTH has beaten EPS estimates 100% of the time and has beaten ...
[[AME]], [[APO]], [[ARCB]], [[ARNC]], [[ATC]], [[BEN]], [[BEP]], [[BERY]], [[BG]], [[BHC]], [[BR]], [[CMI]], [[COP]], [[CQP]], [[CRL]], [[CRSR]], [[CTLT]], [[CVLT]], [[CVS]], [[CWH]], [[D]], [[DD]], [[DEA]], [[ETN]], [[ETRN]], [[EXPD]], [[FI]], [[FSS]], [[GCP]], [[GPN]], [[HEP]], [[HSC]], [[H...
EXINI Diagnostics AB, a subsidiary of Lantheus Holdings, Inc. (NASDAQ: LNTH) (Lantheus), an established leader and fully integrated provider of innovative imaging diagnostics, targeted therapeutics and artificial intelligence (AI) solutions to Find, Fight and Follow serious medical cond...
Lantheus Holdings (LNTH) announces a strategic collaboration with Allegheny Health Network ((AHN)) for the use of its Microbubbles in Combination with ultrasound assisted gene therapy for the development of a proposed treatment for xerostomia, a lack of saliva production leading to ...
Lantheus Holdings, Inc. (NASDAQ: LNTH) (Lantheus), an established leader and fully integrated provider of innovative imaging diagnostics, targeted therapeutics and artificial intelligence solutions to Find, Fight and Follow serious medical conditions, today announced a strategic collabo...
Lantheus Holdings, Inc. (the “Company”) (NASDAQ: LNTH) today announced that it will host a conference call and webcast at 8:00 a.m. ET on Tuesday, May 4, 2021, to discuss its financial and operating results for the first quarter of 2021. To access the live conferen...
Bela Denes, MD Joins as Vice President of Medical Affairs Iryna Teslenko, MD, MBA Joins as Vice President of Clinical Development Lantheus Holdings, Inc. (NASDAQ: LNTH) (Lantheus), an established leader and fully integrated provider of innovative imaging diag...
Lantheus Holdings ([[LNTH]] +9.3%) is likely to record its biggest one-day gain since April 2020 after announcing the acquisition of exclusive, worldwide rights to develop, manufacture and commercialize NTI-1309, a PET oncology imaging agent from Noria Therapeutics.NTI-1309 that tar...
News, Short Squeeze, Breakout and More Instantly...
Lantheus Holdings Inc. Company Name:
LNTH Stock Symbol:
NASDAQ Market:
Lantheus Holdings Inc. Website:
2024-08-01 08:00:12 ET David Turkaly from JMP Securities issued a price target of $125.00 for LNTH on 2024-08-01 07:13:00. The adjusted price target was set to $125.00. At the time of the announcement, LNTH was trading at $104.83. The overall price target consensus is at...
Second Quarter 2024 Worldwide revenue of $394.1 million, an increase of 22.5% from second quarter 2023 Completed three strategic transactions to expand innovative pipeline GAAP fully diluted earnings per share of $0.88, compared to $1.33 in second quarter 2023. Adjusted fully ...
BEDFORD, Mass., July 17, 2024 (GLOBE NEWSWIRE) -- Lantheus Holdings, Inc. (the “Company”) (NASDAQ: LNTH) today announced that it will host a conference call and webcast at 8:00 a.m. ET on Wednesday, July 31, 2024, to discuss its financial and operating results for the second...